Kulasingam Shalini L., Koutsky Laura A.
University of Washington, HPV Research Group, Suite 300, 1914 N. 34th Street, Seattle, WA 98103, USA.
Curr Infect Dis Rep. 2001 Apr;3(2):169-182. doi: 10.1007/s11908-996-0054-0.
With the causal link between specific types of human papillomavirus (HPV) and cervical cancer firmly established, efforts have turned to assessing the relative merits of offering HPV testing in screening, triage, and posttreatment management. Many unanswered questions remain, but a growing body of evidence supports a role for HPV testing in cervical cancer prevention programs. Already, clinical centers that serve thousands of women in Europe and the United States have incorporated HPV DNA tests in triage algorithms.
随着特定类型的人乳头瘤病毒（HPV）与宫颈癌之间的因果联系被牢固确立，人们的努力已转向评估在筛查、分流和治疗后管理中进行HPV检测的相对优势。许多问题仍未得到解答，但越来越多的证据支持HPV检测在宫颈癌预防项目中发挥作用。在欧洲和美国，已经有服务数千名女性的临床中心将HPV DNA检测纳入了分流算法。
